The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Expect thin trading on U.S. Thanksgiving holiday: The Toronto Stock Exchange will be front and centre today, as the ...

Among French lenders, Societe Generale and BNP Paribas fell around 2% each. The risk premium investors demand to hold French debt rose to its highest level since 2012, a sign of investor angst over ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

Grifols to Outline Standalone Strategy After Brookfield Drops Bid Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks for a ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

This article summarizes current health news, covering topics like potential bone loss from thyroid medication, dementia risks from wildfire smoke, and updates on pharmaceutical pricing policies. It ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...